Canada Life
PRNB

Canada Life’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Canada Life’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,522
Closed -$90K – 2750
2020
Q2 		$90K Hold
1,522
– – ﹤0.01% 2074
2020
Q1 		$90K Hold
1,522
– – ﹤0.01% 2004
2019
Q4 		$83K Buy
+1,522
New +$56.8K ﹤0.01% 2118
2019
Q3 		– Sell
-889
Closed -$30K – 2637
2019
Q2 		$30K Buy
+889
New +$27.8K ﹤0.01% 2541

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Canada Life's PRNB Position: Q3 2020 in Review

Canada Life sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 1,522 shares — an estimated $90K sold.

Canada Life first reported a position in PRNB in Q2 2019 and held it in 4 quarters. The position peaked at $90K in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Canada Life reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Canada Life sold 1,522 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $90K.
  • Canada Life first reported a position in Principia Biopharma Inc. Common Stock in Q2 2019 and held it in 4 quarters.
  • Canada Life's Principia Biopharma Inc. Common Stock position peaked at $90K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Canada Life's 13F filing for Q3 2020, filed 13 Nov 2020.